Guidant, J&amp;J reportedly are in merger talks
97019
Johnson &amp; Johnson is in advanced negotiations to acquire Guidant, an Indianapolis-based medical device maker, for more than $24 billion, executives close to the talks said Monday.
59122
Stocks looked to open slightly higher  on Tuesday, with Wall Street welcoming a slip in oil prices and  news of a possible merger between Johnson & Johnson JNJ.N and  cardiovascular device maker Guidant Corp. GDT.N.
607732
Shares of cardiovascular device maker  Guidant Corp. GDT.N jumped 6 percent on Tuesday, following a  report that Johnson & Johnson JNJ.N is in advanced talks to  buy it for more than $24 billion.
628521
Oracle Corp.  on Thursday said it is in merger talks with other technology companies as it pursues its &#36;9.2 billion hostile takeover bid for rival software maker PeopleSoft Inc. .
723657
Could a jointly marketed drug lead to a joint company? Ireland&#39;s Sunday Tribune said yesterday that US pharmaceuticals company Biogen Idec (nasdaq: BIIB - news - people ) was looking to make an all-stock bid
349327
UAL Corp.'s  United Airlines is in preliminary talks with Continental Airlines  about a possible merger, according to media reports on Tuesday.
249844
CHICAGO/PHILADELPHIA  - Health care and consumer  products maker Johnson & Johnson JNJ.N is in negotiations to  acquire medical-device maker Guidant Corp. GDT.N, sources  familiar with the situation said on Tuesday.
346636
Stocks to watch on Tuesday: JOHNSON & JOHNSON , GUIDANT CORP.
102025
Slow sales and slashed workforces have reportedly prompted executives from the two ailing auto giants to talk about an alliance - or even a merger
667631
The prospect of Johnson &amp; Johnson acquiring Guidant, a medical device maker that brought cutting-edge technology to cardiovascular medicine, has fueled whispers for years, gaining intensity when
413006
Sprint and Nextel, two large US mobile companies, are discussing a possible $70bn merger, according to newspaper reports.
54351
Executives told The New York Times the two companies may be set to merge.
429216
Drug giant Johnson & Johnson is working on a $24bn purchase of medical device firm Guidant Corp, a key player in the heart technology market.
597753
The exchanges said they are in preliminary talks on a merger that could create one of the biggest marketplaces for derivatives in the world.
16804
Johnson &amp; Johnson Chief Executive Officer William Weldon plans to use the $25 billion purchase of defibrillator maker Guidant Corp.
605466
Johnson &amp; Johnson last night struck a deal to acquire Guidant, the US cardiac treatment group for $25.4bn, in a move that will give it access to one of the fastest growing areas in health care.
177578
Even as the ink dries on Johnson &amp; Johnson&#39;s agreement to buy Guidant Corp. for $25.4 billion, it remains on the hunt for other companies that could bolster